Health in Ethiopia 1,318 indicators covering health for Ethiopia. IndicatorLatest Year10-yr change Rank Number of people operated for trachomatous trichiasis 79,586 2025 down 29.0% 1st Tuberculosis prevalence rate 237 per 1000,000 population, WHO 2011 down 42.1% 27th Current use of contraception (modern method) (% of married women): Q1 26.7% 2019 up 105.4% 24th Current use of contraception (modern method) (% of married women): Q2 35.1% 2019 up 63.3% 22nd Current use of contraception (modern method) (% of married women): Q3 44.6% 2019 up 85.8% 19th Current use of contraception (modern method) (% of married women): Q4 42.9% 2019 up 41.6% 19th Current use of contraception (modern method) (% of married women): Q5 50.6% 2019 up 5.0% 17th Current use of contraception (any method) (% of married women): Q1 27.0% 2019 up 103.0% 25th Current use of contraception (any method) (% of married women): Q2 35.3% 2019 up 59.0% 24th Current use of contraception (any method) (% of married women): Q3 45.2% 2019 up 85.2% 22nd Current use of contraception (any method) (% of married women): Q4 44.0% 2019 up 38.8% 24th Current use of contraception (any method) (% of married women): Q5 53.0% 2019 up 2.3% 19th Compliance with international health regulations 79 2016 up 97.5% 67th Number of malaria cases treated with any first line tx courses 4.32 million 2024 up 477.4% 15th Number of indigenous P. vivax malaria cases 1.51 million 2024 up 122.2% 2nd Vaccinations (BCG) (% of children ages 12-23 months): Q1 52.6% 2019 down 9.3% 41st Vaccinations (BCG) (% of children ages 12-23 months): Q2 68.7% 2019 up 4.4% 39th Vaccinations (BCG) (% of children ages 12-23 months): Q3 68.5% 2019 up 10.8% 41st Vaccinations (BCG) (% of children ages 12-23 months): Q4 77.4% 2019 up 13.7% 41st Vaccinations (BCG) (% of children ages 12-23 months): Q5 93.8% 2019 up 13.6% 34th Vaccinations (Measles) (% of children ages 12-23 months): Q1 42.1% 2019 down 7.1% 39th Vaccinations (Measles) (% of children ages 12-23 months): Q2 53.9% 2019 up 3.7% 38th Vaccinations (Measles) (% of children ages 12-23 months): Q3 46.1% 2019 down 11.3% 41st Vaccinations (Measles) (% of children ages 12-23 months): Q4 62.2% 2019 up 10.3% 39th Vaccinations (Measles) (% of children ages 12-23 months): Q5 82.4% 2019 up 3.4% 28th Prevalence of undernourishment 34 population 2011 down 5.6% 1st Deaths and disappearances during migration 5 2024 down 81.5% 48th Vaccinations (all vaccinations) (% of children ages 12-23 months): Q1 26.4% 2019 up 57.1% 37th Vaccinations (all vaccinations) (% of children ages 12-23 months): Q2 42.5% 2019 up 133.5% 35th Vaccinations (all vaccinations) (% of children ages 12-23 months): Q3 35.4% 2019 up 94.5% 37th Vaccinations (all vaccinations) (% of children ages 12-23 months): Q4 42.6% 2019 up 71.1% 37th Vaccinations (all vaccinations) (% of children ages 12-23 months): Q5 67.0% 2019 up 32.7% 25th Incidence of tuberculosis, high uncertainty bound 335 per 100,000 people 2011 down 45.6% 19th Incidence of tuberculosis, low uncertainty bound 191 per 100,000 people 2011 down 21.4% 24th Tuberculosis prevalence rate, high uncertainty bound 288 per 1000,000 population, WHO 2011 down 45.6% 35th Tuberculosis prevalence rate, low uncertainty bound 191 per 1000,000 population, WHO 2011 down 37.2% 20th Vaccinations (DPT 3) (% of children ages 12-23 months): Q1 47.0% 2019 up 80.8% 35th Vaccinations (DPT 3) (% of children ages 12-23 months): Q2 57.9% 2019 up 96.9% 35th Vaccinations (DPT 3) (% of children ages 12-23 months): Q3 50.8% 2019 up 63.9% 35th Vaccinations (DPT 3) (% of children ages 12-23 months): Q4 59.7% 2019 up 41.5% 37th Vaccinations (DPT 3) (% of children ages 12-23 months): Q5 83.4% 2019 up 35.6% 30th Vaccinations (no vaccinations) (% of children ages 12-23 months): Q1 35.6% 2019 up 118.4% 2nd Vaccinations (no vaccinations) (% of children ages 12-23 months): Q2 20.1% 2019 up 23.3% 4th Vaccinations (no vaccinations) (% of children ages 12-23 months): Q3 23.8% 2019 up 35.2% 2nd Vaccinations (no vaccinations) (% of children ages 12-23 months): Q4 15.5% 2019 down 5.5% 2nd Vaccinations (no vaccinations) (% of children ages 12-23 months): Q5 3.9% 2019 up 11.4% 10th Reported clinical malaria cases 1.48 million total 2011 down 42.1% 8th Number of malaria cases treated with artemisinin-based combination 2.81 million 2024 up 275.8% 16th Number of imported cases of cutaneous leishmaniasis reported 0 2024 — 34th Number of people protected from malaria by indoor residual spraying 5.61 million 2024 down 65.2% 4th Place of delivery (births at health facility) (% of births): Q1 20.9% 2019 up 674.1% 33rd Place of delivery (births at health facility) (% of births): Q2 41.2% 2019 up 1,229.0% 33rd Place of delivery (births at health facility) (% of births): Q3 47.3% 2019 up 1,251.4% 33rd Place of delivery (births at health facility) (% of births): Q4 65.8% 2019 up 743.6% 32nd Place of delivery (births at health facility) (% of births): Q5 86.5% 2019 up 76.2% 32nd Number of imported cases of visceral leishmaniasis reported 0 2024 down 100.0% 22nd Exclusive breastfeeding under six months 58.8 2019 up 13.1% 16th Exclusive breastfeeding under six months 1,088 2019 up 31.7% 3rd Exclusive breastfeeding 58.81 2019 up 13.2% 16th Under-5 mortality rate (per 1,000 live births): Q1 77 lowest 2019 down 43.8% 16th ← Previous Page 21 of 22 Next →